Covid Vaccine Passports

Mark Harper Excerpts

Wednesday 8th September 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful to the hon. Lady for her opening words and for urging those who have not had a vaccine to come forward and be protected. She asked a number of important questions relating to this measure, including what it will achieve. She will know that double vaccination was important for people to be able to travel, and the implementation of that was largely successful. We need to go further to make sure that we recognise other vaccines from other countries around the world. Those vaccines need to be recognised by the WHO, our regulator and other regulators to make it even easier for people who are double vaccinated to travel to the United Kingdom. The NHS in England, Scotland, Wales and Northern Ireland stands ready to continue that joint work, as does NHSX in terms of the technology.

The hon. Lady asked about people’s access to essential settings, which is incredibly important. I can assure her that some essential services will not require people to show covid vaccine certification. They include settings that have stayed open throughout the pandemic, such as public sector buildings, essential retail, essential services and, of course, public transport.

She also asked what certification will achieve domestically. I hope that, combined with the vaccination programme, the booster programme and all the work that we have done around education, we will be able to transition this virus, post winter, from pandemic to endemic status. The reason for this very difficult decision is that it allows us to sustain the opening of the economy, including the nightclub sector, without having to flip-flop, go backwards and close down sectors because of super-spreader events. The chief medical officer, Chris Whitty, tells us that in absolute terms. As I said earlier, if people are double jabbed, only 60% will not be infected by the virus and therefore not spread it, but 40% could be infected. In relative terms, putting that downward pressure on infection rates is important in that journey towards transition from pandemic to endemic.

[Mr Mark Harper (Forest of Dean) (Con)]

I have to say that I agree with the Chairman of the Public Administration and Constitutional Affairs Committee, my hon. Friend the Member for Hazel Grove (Mr Wragg). The Minister set out earlier this year that this policy was discriminatory. He was right then and that remains the case. It is a discriminatory policy. The vaccines are fantastically effective at reducing hospitalisation and death. They are very much less effective in reducing transmission of the Delta variant. This is a pointless policy with damaging effects. I am afraid that the Minister is picking an unnecessary fight with his own colleagues. I say to him that the Government should think again. The Leader of the House has been clear that we do not believe—the Government do not believe—that this policy is necessary for us to meet here in a crowded place. Let us not have one rule for Members of Parliament and another rule for everybody else. Drop this policy.

[Nadhim Zahawi]

My right hon. Friend asks about my previous position. I addressed it a few days ago from this Dispatch Box. Back in January and February, we did not have the level of evidence on the Delta variant, which he mentioned. That variant is far more infectious—it requires only a few particles of Delta for a person to be infectious. Let me repeat the data that I cited earlier: 60% of people who are double vaccinated will not be infected by Delta and therefore will not spread it, but 40% could be infected and then spread it.

As for the policy being discriminatory, there will, of course, be exemptions—for example, in exceptional circumstances where a clinician recommends vaccine deferral, where that vaccine is not appropriate, and where testing is also not recommended on clinical grounds. Then there are those who have received a trial vaccine, including those who have been blinded or given a placebo as part of the formally approved covid vaccine trials in the United Kingdom.

This is not something that we enter into lightly, but it is part of our armoury to help us transition over the winter months from pandemic to endemic status. I hope to be able to stand at this Dispatch Box very soon after that and be able to share with the House that we do not need to do this any more as we will be dealing with the virus through an annual vaccination programme.